Quality of pediatric second-degree burn wound scars following the application of basic fibroblast growth factor: results of a randomized, controlled pilot study
- PMID: 22879314
Quality of pediatric second-degree burn wound scars following the application of basic fibroblast growth factor: results of a randomized, controlled pilot study
Abstract
Pediatric burn wounds present unique challenges. Second-degree burns may increase in size and depth, raising concerns about healing and long-term scarring. Results of a clinical study in adults with second-degree burn wounds suggest that application of basic fibroblast growth factor (bFGF) may reduce time to second-intention healing and result in a more cosmetically acceptable scar. To evaluate the effect of this treatment on pediatric patients with deep second- degree burn wounds, 20 pediatric patients ranging in age from 8 months to 3 years (average 1 year, 3 months [± 6 months]) with a total of 30 burn wounds from various causes were allocated either the growth factor (treatment, n = 15) or an impregnated gauze treatment (control, n = 15). Wounds still exudative (not healed) after 21 days were covered with a split-thickness skin graft. All wounds were clinically assessed until healed and after 1 year. A moisture meter was used to assess scars of wounds healing by secondary intention. A color meter was used to evaluate grafted wounds. Five wounds in each group required grafting. Skin/scar color match was significantly closer to 100% in the treatment than in the control group (P <0.01). Wounds not requiring grafting were no longer exudative after 13.8 (± 2.4) and 17.5 (± 3.1) days in the treatment (n = 10) and control group (n = 10), respectively (P <0.01). After 1 year, scar pigmentation, pliability, height, and vascularity were also significantly different (P <0.01) between the groups. Hypertrophic scars developed in 0 of 10 wounds in the treatment and in three of 10 wounds in the control group, and effective contact coefficient, transepidermal water loss, water content, and scar thickness were significantly greater in control group (P <0.01). Both the short- and long-term results of this treatment in pediatric burn patients are encouraging and warrant further research.
Similar articles
-
The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor.J Burn Care Res. 2006 May-Jun;27(3):333-8. doi: 10.1097/01.BCR.0000216742.23127.7A. J Burn Care Res. 2006. PMID: 16679903
-
Recombinant bovine basic fibroblast growth factor accelerates wound healing in patients with burns, donor sites and chronic dermal ulcers.Chin Med J (Engl). 2000 Apr;113(4):367-71. Chin Med J (Engl). 2000. PMID: 11775238 Clinical Trial.
-
Basic fibroblast growth factor accelerates and improves second-degree burn wound healing.Wound Repair Regen. 2008 Sep-Oct;16(5):635-41. doi: 10.1111/j.1524-475X.2008.00414.x. Wound Repair Regen. 2008. PMID: 19128258 Clinical Trial.
-
Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.Philos Trans R Soc Lond B Biol Sci. 2004 May 29;359(1445):839-50. doi: 10.1098/rstb.2004.1475. Philos Trans R Soc Lond B Biol Sci. 2004. PMID: 15293811 Free PMC article. Review.
-
Are corticosteroids effective for prevention of scar formation after second-degree skin burn?J Dermatolog Treat. 2014 Aug;25(4):360-2. doi: 10.3109/09546634.2013.806768. Epub 2013 Jun 7. J Dermatolog Treat. 2014. PMID: 23688200 Review.
Cited by
-
Advances in surgical applications of growth factors for wound healing.Burns Trauma. 2019 Apr 5;7:10. doi: 10.1186/s41038-019-0148-1. eCollection 2019. Burns Trauma. 2019. PMID: 30993143 Free PMC article. Review.
-
Roles of the fibroblast growth factor signal transduction system in tissue injury repair.Burns Trauma. 2022 Mar 23;10:tkac005. doi: 10.1093/burnst/tkac005. eCollection 2022. Burns Trauma. 2022. PMID: 35350443 Free PMC article. Review.
-
Strategies to enhance the efficacy of FGF2-based therapies for skin wound healing.Arch Dermatol Res. 2024 Jun 15;316(7):405. doi: 10.1007/s00403-024-02953-x. Arch Dermatol Res. 2024. PMID: 38878084 Review.
-
Nanocarrier-Mediated Topical Insulin Delivery for Wound Healing.Materials (Basel). 2021 Jul 30;14(15):4257. doi: 10.3390/ma14154257. Materials (Basel). 2021. PMID: 34361451 Free PMC article. Review.
-
The Japanese Experience with Basic Fibroblast Growth Factor in Cutaneous Wound Management and Scar Prevention: A Systematic Review of Clinical and Biological Aspects.Dermatol Ther (Heidelb). 2020 Aug;10(4):569-587. doi: 10.1007/s13555-020-00407-6. Epub 2020 Jun 6. Dermatol Ther (Heidelb). 2020. PMID: 32506250 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical